Alina Nussbaumer-Proll
Overview
Explore the profile of Alina Nussbaumer-Proll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jorda A, Pracher L, Eberl S, Nussbaumer-Proll A, Sarhan M, Weber M, et al.
Med Microbiol Immunol
. 2025 Mar;
214(1):14.
PMID: 40047923
Whether the magnitude of individual cytokine, cellular, and clinical responses to the intravenous lipopolysaccharide (LPS) challenge is constant in individuals over extended time periods is unknown. Nine healthy volunteers received...
2.
Leutzendorff A, Al Jalali V, Bauer M, Minichmayr I, Reiter B, Duchek M, et al.
Br J Clin Pharmacol
. 2024 Oct;
91(3):808-816.
PMID: 39428980
Aims: Clomipramine (CLOMI) has shown effectiveness in treating premature ejaculation but is linked to erectile dysfunction and reduced libido. Yohimbine (YOH), by contrast, is effective in treating erectile dysfunction and...
3.
Jorda A, Eberl S, Nussbaumer-Proll A, Sarhan M, Weber M, Tegrovsky L, et al.
J Inflamm Res
. 2024 Jul;
17:4781-4790.
PMID: 39051050
Introduction: Lipopolysaccharide (LPS) stimulation of human whole blood ex vivo has been widely used to investigate human innate immune responses. However, there are uncertainties regarding the reproducibility and reliability of...
4.
van Os W, Nussbaumer-Proll A, Pham A, Wijnant G, Ngougni Pokem P, Van Bambeke F, et al.
J Antimicrob Chemother
. 2024 Jul;
79(10):2484-2492.
PMID: 39030832
Background: Temocillin is increasingly considered as an alternative to carbapenems. However, there is no consensus on optimal dosing strategies and limited data on temocillin efficacy in systemic infections. Objectives: We...
5.
Nussbaumer-Proll A, Matzneller P, Eberl S, Zeitlinger M
Eur J Clin Microbiol Infect Dis
. 2024 Mar;
43(5):927-936.
PMID: 38483681
Purpose: This study investigates how surfactants affect the in-vitro anti-infective efficacy of micafungin, caspofungin, anidulafungin, and amphotericin B in treating pulmonary mycoses. Methods: MIC values for antifungal agents were determined...
6.
Bauer M, Jorda A, Al-Jalali V, Wolfl-Duchek M, Bergmann F, Nussbaumer-Proll A, et al.
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38375429
Background: APN01 is a soluble recombinant human angiotensin-converting enzyme 2 (rhACE2), a key player in the renin-aldosterone-angiotensin system (RAAS). In clinical studies, APN01 was administered intravenously only, so far. The...
7.
Bergmann F, Nussbaumer-Proll A, Wulkersdorfer B, Eberl S, Ruppitsch W, Lepuschitz S, et al.
J Glob Antimicrob Resist
. 2023 Jul;
34:179-185.
PMID: 37473915
Objectives: Although generic medicinal products are required to have the same qualitative and quantitative composition of the active substance as their reference originator product, patients and health care professionals express...
8.
Jorda A, Gabler C, Blaschke A, Wolfl-Duchek M, Gelbenegger G, Nussbaumer-Proll A, et al.
Infection
. 2023 Jun;
52(1):105-115.
PMID: 37326938
Background: Bacterial co-infections are believed to be less frequent in patients with Covid-19 than influenza, but frequencies varied between studies. Methods: This single-center retrospective, propensity score-matched analysis included adult patients...
9.
Bergmann F, Gabler C, Nussbaumer-Proll A, Wolfl-Duchek M, Blaschke A, Radtke C, et al.
Crit Care Explor
. 2023 Apr;
5(4):e0895.
PMID: 37066070
Objectives: This study aimed to compare the rate of early bacterial coinfections in ICU patients with COVID-19 or influenza. Design Setting And Participants: Retrospective propensity score matched cohort study. We...
10.
Bergmann F, Jorda A, Blaschke A, Gabler C, Bohdan S, Nussbaumer-Proll A, et al.
J Fungi (Basel)
. 2023 Mar;
9(3).
PMID: 36983483
COVID-19-associated pulmonary aspergillosis (CAPA) is a life-threatening fungal infection that mainly affects critically ill patients. The aim of this study was to assess the incidence and clinical outcomes of putative...